1 Min Read
Moleculin Biotech Inc:
* MOLECULIN BIOTECH INC - HAS BEEN ABLE TO SHOW PROMISING TUMOR SUPPRESSION ACTIVITY WITH ITS INHIBITOR OF GLYCOLYSIS, WP1122 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.